nodes	percent_of_prediction	percent_of_DWPC	metapath
Norfloxacin—TOP2A—Epirubicin—testicular cancer	0.141	0.177	CbGbCtD
Norfloxacin—TOP2A—Etoposide—testicular cancer	0.109	0.138	CbGbCtD
Norfloxacin—SLC22A5—Dactinomycin—testicular cancer	0.102	0.129	CbGbCtD
Norfloxacin—CYP2A6—Ifosfamide—testicular cancer	0.0918	0.115	CbGbCtD
Norfloxacin—TOP2A—Doxorubicin—testicular cancer	0.0747	0.0939	CbGbCtD
Norfloxacin—CYP3A7—Ifosfamide—testicular cancer	0.0628	0.0789	CbGbCtD
Norfloxacin—CYP3A7-CYP3A51P—Ifosfamide—testicular cancer	0.0628	0.0789	CbGbCtD
Norfloxacin—CYP3A5—Ifosfamide—testicular cancer	0.0471	0.0592	CbGbCtD
Norfloxacin—CYP3A5—Etoposide—testicular cancer	0.0225	0.0283	CbGbCtD
Norfloxacin—SLC22A6—Methotrexate—testicular cancer	0.0217	0.0273	CbGbCtD
Norfloxacin—CYP3A4—Ifosfamide—testicular cancer	0.0184	0.0231	CbGbCtD
Norfloxacin—CYP1A2—Etoposide—testicular cancer	0.0167	0.0211	CbGbCtD
Norfloxacin—CYP3A4—Vinblastine—testicular cancer	0.00974	0.0122	CbGbCtD
Norfloxacin—CYP3A4—Etoposide—testicular cancer	0.00877	0.011	CbGbCtD
Norfloxacin—CYP3A4—Doxorubicin—testicular cancer	0.00598	0.00753	CbGbCtD
Norfloxacin—TOP2A—Vindesine—Vinblastine—testicular cancer	0.00102	0.188	CbGdCrCtD
Norfloxacin—TOP2A—Vinorelbine—Vinblastine—testicular cancer	0.000643	0.118	CbGdCrCtD
Norfloxacin—TOP2A—Podofilox—Etoposide—testicular cancer	0.000643	0.118	CbGdCrCtD
Norfloxacin—TOP2A—Teniposide—Etoposide—testicular cancer	0.000643	0.118	CbGdCrCtD
Norfloxacin—TOP2A—Vincristine—Vinblastine—testicular cancer	0.00055	0.101	CbGdCrCtD
Norfloxacin—TOP2A—Doxorubicin—Epirubicin—testicular cancer	0.000335	0.0617	CbGdCrCtD
Norfloxacin—TOP2A—Idarubicin—Epirubicin—testicular cancer	0.000335	0.0617	CbGdCrCtD
Norfloxacin—TOP2A—Daunorubicin—Epirubicin—testicular cancer	0.000335	0.0617	CbGdCrCtD
Norfloxacin—TOP2A—Idarubicin—Doxorubicin—testicular cancer	0.00031	0.0571	CbGdCrCtD
Norfloxacin—TOP2A—Epirubicin—Doxorubicin—testicular cancer	0.00031	0.0571	CbGdCrCtD
Norfloxacin—TOP2A—Daunorubicin—Doxorubicin—testicular cancer	0.00031	0.0571	CbGdCrCtD
Norfloxacin—Anaphylactic shock—Etoposide—testicular cancer	0.000209	0.00105	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000208	0.00104	CcSEcCtD
Norfloxacin—Ataxia—Doxorubicin—testicular cancer	0.000208	0.00104	CcSEcCtD
Norfloxacin—Asthenia—Dactinomycin—testicular cancer	0.000207	0.00104	CcSEcCtD
Norfloxacin—Blood creatinine increased—Doxorubicin—testicular cancer	0.000207	0.00104	CcSEcCtD
Norfloxacin—Dysphagia—Epirubicin—testicular cancer	0.000206	0.00103	CcSEcCtD
Norfloxacin—Neutropenia—Methotrexate—testicular cancer	0.000206	0.00103	CcSEcCtD
Norfloxacin—Paraesthesia—Cisplatin—testicular cancer	0.000205	0.00103	CcSEcCtD
Norfloxacin—Thrombocytopenia—Etoposide—testicular cancer	0.000205	0.00103	CcSEcCtD
Norfloxacin—Eosinophilia—Epirubicin—testicular cancer	0.000204	0.00102	CcSEcCtD
Norfloxacin—Liver function test abnormal—Doxorubicin—testicular cancer	0.000204	0.00102	CcSEcCtD
Norfloxacin—Dyspnoea—Cisplatin—testicular cancer	0.000204	0.00102	CcSEcCtD
Norfloxacin—Hyperhidrosis—Etoposide—testicular cancer	0.000202	0.00101	CcSEcCtD
Norfloxacin—Pancreatitis—Epirubicin—testicular cancer	0.000202	0.00101	CcSEcCtD
Norfloxacin—Orthostatic hypotension—Doxorubicin—testicular cancer	0.000202	0.00101	CcSEcCtD
Norfloxacin—Photosensitivity reaction—Methotrexate—testicular cancer	0.000201	0.00101	CcSEcCtD
Norfloxacin—Anorexia—Etoposide—testicular cancer	0.000199	0.001	CcSEcCtD
Norfloxacin—Toxic epidermal necrolysis—Doxorubicin—testicular cancer	0.000199	0.000997	CcSEcCtD
Norfloxacin—Aspartate aminotransferase increased—Doxorubicin—testicular cancer	0.000199	0.000997	CcSEcCtD
Norfloxacin—Decreased appetite—Cisplatin—testicular cancer	0.000198	0.000996	CcSEcCtD
Norfloxacin—Diarrhoea—Dactinomycin—testicular cancer	0.000198	0.000992	CcSEcCtD
Norfloxacin—Vomiting—Bleomycin—testicular cancer	0.000197	0.000988	CcSEcCtD
Norfloxacin—Drowsiness—Methotrexate—testicular cancer	0.000196	0.000985	CcSEcCtD
Norfloxacin—Rash—Bleomycin—testicular cancer	0.000195	0.00098	CcSEcCtD
Norfloxacin—Dermatitis—Bleomycin—testicular cancer	0.000195	0.000979	CcSEcCtD
Norfloxacin—Hypersensitivity—Ifosfamide—testicular cancer	0.000195	0.000979	CcSEcCtD
Norfloxacin—Stevens-Johnson syndrome—Methotrexate—testicular cancer	0.000195	0.000977	CcSEcCtD
Norfloxacin—Renal failure—Methotrexate—testicular cancer	0.000193	0.000969	CcSEcCtD
Norfloxacin—Neutropenia—Epirubicin—testicular cancer	0.000193	0.000967	CcSEcCtD
Norfloxacin—Stomatitis—Methotrexate—testicular cancer	0.000191	0.000961	CcSEcCtD
Norfloxacin—Conjunctivitis—Methotrexate—testicular cancer	0.000191	0.000958	CcSEcCtD
Norfloxacin—Dysphagia—Doxorubicin—testicular cancer	0.000191	0.000957	CcSEcCtD
Norfloxacin—Asthenia—Ifosfamide—testicular cancer	0.00019	0.000953	CcSEcCtD
Norfloxacin—Eosinophilia—Doxorubicin—testicular cancer	0.000189	0.000948	CcSEcCtD
Norfloxacin—Photosensitivity reaction—Epirubicin—testicular cancer	0.000188	0.000944	CcSEcCtD
Norfloxacin—Feeling abnormal—Cisplatin—testicular cancer	0.000188	0.000944	CcSEcCtD
Norfloxacin—Paraesthesia—Etoposide—testicular cancer	0.000188	0.000942	CcSEcCtD
Norfloxacin—Pruritus—Ifosfamide—testicular cancer	0.000187	0.00094	CcSEcCtD
Norfloxacin—Haematuria—Methotrexate—testicular cancer	0.000187	0.00094	CcSEcCtD
Norfloxacin—Pancreatitis—Doxorubicin—testicular cancer	0.000187	0.000938	CcSEcCtD
Norfloxacin—Dyspnoea—Etoposide—testicular cancer	0.000186	0.000935	CcSEcCtD
Norfloxacin—Somnolence—Etoposide—testicular cancer	0.000186	0.000933	CcSEcCtD
Norfloxacin—Nausea—Bleomycin—testicular cancer	0.000184	0.000923	CcSEcCtD
Norfloxacin—Drowsiness—Epirubicin—testicular cancer	0.000184	0.000922	CcSEcCtD
Norfloxacin—Vomiting—Dactinomycin—testicular cancer	0.000184	0.000922	CcSEcCtD
Norfloxacin—Agranulocytosis—Methotrexate—testicular cancer	0.000183	0.00092	CcSEcCtD
Norfloxacin—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.000182	0.000914	CcSEcCtD
Norfloxacin—Rash—Dactinomycin—testicular cancer	0.000182	0.000914	CcSEcCtD
Norfloxacin—Decreased appetite—Etoposide—testicular cancer	0.000182	0.000912	CcSEcCtD
Norfloxacin—Diarrhoea—Ifosfamide—testicular cancer	0.000181	0.000909	CcSEcCtD
Norfloxacin—Renal failure—Epirubicin—testicular cancer	0.000181	0.000907	CcSEcCtD
Norfloxacin—Body temperature increased—Cisplatin—testicular cancer	0.00018	0.000905	CcSEcCtD
Norfloxacin—Fatigue—Etoposide—testicular cancer	0.00018	0.000905	CcSEcCtD
Norfloxacin—Neuropathy peripheral—Epirubicin—testicular cancer	0.00018	0.000904	CcSEcCtD
Norfloxacin—Jaundice—Epirubicin—testicular cancer	0.000179	0.000899	CcSEcCtD
Norfloxacin—Stomatitis—Epirubicin—testicular cancer	0.000179	0.000899	CcSEcCtD
Norfloxacin—Constipation—Etoposide—testicular cancer	0.000179	0.000897	CcSEcCtD
Norfloxacin—Conjunctivitis—Epirubicin—testicular cancer	0.000179	0.000896	CcSEcCtD
Norfloxacin—Neutropenia—Doxorubicin—testicular cancer	0.000178	0.000895	CcSEcCtD
Norfloxacin—Hepatitis—Methotrexate—testicular cancer	0.000176	0.000885	CcSEcCtD
Norfloxacin—Haematuria—Epirubicin—testicular cancer	0.000175	0.000879	CcSEcCtD
Norfloxacin—Dizziness—Ifosfamide—testicular cancer	0.000175	0.000879	CcSEcCtD
Norfloxacin—Photosensitivity reaction—Doxorubicin—testicular cancer	0.000174	0.000874	CcSEcCtD
Norfloxacin—Feeling abnormal—Etoposide—testicular cancer	0.000172	0.000865	CcSEcCtD
Norfloxacin—Nausea—Dactinomycin—testicular cancer	0.000172	0.000861	CcSEcCtD
Norfloxacin—Agranulocytosis—Epirubicin—testicular cancer	0.000172	0.000861	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Etoposide—testicular cancer	0.000171	0.000858	CcSEcCtD
Norfloxacin—Drowsiness—Doxorubicin—testicular cancer	0.00017	0.000853	CcSEcCtD
Norfloxacin—Visual impairment—Methotrexate—testicular cancer	0.00017	0.000853	CcSEcCtD
Norfloxacin—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.000169	0.000846	CcSEcCtD
Norfloxacin—Vomiting—Ifosfamide—testicular cancer	0.000168	0.000845	CcSEcCtD
Norfloxacin—Hypersensitivity—Cisplatin—testicular cancer	0.000168	0.000844	CcSEcCtD
Norfloxacin—Renal failure—Doxorubicin—testicular cancer	0.000167	0.000839	CcSEcCtD
Norfloxacin—Rash—Ifosfamide—testicular cancer	0.000167	0.000838	CcSEcCtD
Norfloxacin—Dermatitis—Ifosfamide—testicular cancer	0.000167	0.000837	CcSEcCtD
Norfloxacin—Erythema multiforme—Methotrexate—testicular cancer	0.000167	0.000836	CcSEcCtD
Norfloxacin—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000167	0.000836	CcSEcCtD
Norfloxacin—Urticaria—Etoposide—testicular cancer	0.000166	0.000834	CcSEcCtD
Norfloxacin—Stomatitis—Doxorubicin—testicular cancer	0.000166	0.000832	CcSEcCtD
Norfloxacin—Jaundice—Doxorubicin—testicular cancer	0.000166	0.000832	CcSEcCtD
Norfloxacin—Abdominal pain—Etoposide—testicular cancer	0.000165	0.000829	CcSEcCtD
Norfloxacin—Body temperature increased—Etoposide—testicular cancer	0.000165	0.000829	CcSEcCtD
Norfloxacin—Conjunctivitis—Doxorubicin—testicular cancer	0.000165	0.000829	CcSEcCtD
Norfloxacin—Hepatitis—Epirubicin—testicular cancer	0.000165	0.000828	CcSEcCtD
Norfloxacin—Tinnitus—Methotrexate—testicular cancer	0.000164	0.000825	CcSEcCtD
Norfloxacin—Hypoaesthesia—Epirubicin—testicular cancer	0.000164	0.000824	CcSEcCtD
Norfloxacin—Asthenia—Cisplatin—testicular cancer	0.000164	0.000822	CcSEcCtD
Norfloxacin—Haematuria—Doxorubicin—testicular cancer	0.000162	0.000814	CcSEcCtD
Norfloxacin—Visual impairment—Epirubicin—testicular cancer	0.000159	0.000798	CcSEcCtD
Norfloxacin—Agranulocytosis—Doxorubicin—testicular cancer	0.000159	0.000796	CcSEcCtD
Norfloxacin—Chills—Methotrexate—testicular cancer	0.000158	0.000794	CcSEcCtD
Norfloxacin—Nausea—Ifosfamide—testicular cancer	0.000157	0.000789	CcSEcCtD
Norfloxacin—Diarrhoea—Cisplatin—testicular cancer	0.000156	0.000784	CcSEcCtD
Norfloxacin—Erythema multiforme—Epirubicin—testicular cancer	0.000156	0.000783	CcSEcCtD
Norfloxacin—Hypersensitivity—Etoposide—testicular cancer	0.000154	0.000773	CcSEcCtD
Norfloxacin—Tinnitus—Epirubicin—testicular cancer	0.000154	0.000772	CcSEcCtD
Norfloxacin—Erythema—Methotrexate—testicular cancer	0.000153	0.00077	CcSEcCtD
Norfloxacin—Hepatitis—Doxorubicin—testicular cancer	0.000153	0.000766	CcSEcCtD
Norfloxacin—Hypoaesthesia—Doxorubicin—testicular cancer	0.000152	0.000762	CcSEcCtD
Norfloxacin—Dysgeusia—Methotrexate—testicular cancer	0.00015	0.000754	CcSEcCtD
Norfloxacin—Asthenia—Etoposide—testicular cancer	0.00015	0.000753	CcSEcCtD
Norfloxacin—Back pain—Methotrexate—testicular cancer	0.000148	0.000745	CcSEcCtD
Norfloxacin—Chills—Epirubicin—testicular cancer	0.000148	0.000743	CcSEcCtD
Norfloxacin—Pruritus—Etoposide—testicular cancer	0.000148	0.000742	CcSEcCtD
Norfloxacin—Visual impairment—Doxorubicin—testicular cancer	0.000147	0.000738	CcSEcCtD
Norfloxacin—Vomiting—Cisplatin—testicular cancer	0.000145	0.000728	CcSEcCtD
Norfloxacin—Vision blurred—Methotrexate—testicular cancer	0.000145	0.000726	CcSEcCtD
Norfloxacin—Erythema multiforme—Doxorubicin—testicular cancer	0.000144	0.000724	CcSEcCtD
Norfloxacin—Rash—Cisplatin—testicular cancer	0.000144	0.000722	CcSEcCtD
Norfloxacin—Dermatitis—Cisplatin—testicular cancer	0.000144	0.000721	CcSEcCtD
Norfloxacin—Erythema—Epirubicin—testicular cancer	0.000144	0.000721	CcSEcCtD
Norfloxacin—Diarrhoea—Etoposide—testicular cancer	0.000143	0.000718	CcSEcCtD
Norfloxacin—Tinnitus—Doxorubicin—testicular cancer	0.000142	0.000714	CcSEcCtD
Norfloxacin—Flatulence—Epirubicin—testicular cancer	0.000142	0.00071	CcSEcCtD
Norfloxacin—Tension—Epirubicin—testicular cancer	0.000141	0.000707	CcSEcCtD
Norfloxacin—Dysgeusia—Epirubicin—testicular cancer	0.000141	0.000706	CcSEcCtD
Norfloxacin—Nervousness—Epirubicin—testicular cancer	0.00014	0.0007	CcSEcCtD
Norfloxacin—Back pain—Epirubicin—testicular cancer	0.000139	0.000697	CcSEcCtD
Norfloxacin—Dizziness—Etoposide—testicular cancer	0.000138	0.000694	CcSEcCtD
Norfloxacin—Muscle spasms—Epirubicin—testicular cancer	0.000138	0.000693	CcSEcCtD
Norfloxacin—Vertigo—Methotrexate—testicular cancer	0.000138	0.000692	CcSEcCtD
Norfloxacin—Leukopenia—Methotrexate—testicular cancer	0.000137	0.000689	CcSEcCtD
Norfloxacin—Chills—Doxorubicin—testicular cancer	0.000137	0.000687	CcSEcCtD
Norfloxacin—Nausea—Cisplatin—testicular cancer	0.000136	0.00068	CcSEcCtD
Norfloxacin—Vision blurred—Epirubicin—testicular cancer	0.000135	0.000679	CcSEcCtD
Norfloxacin—Convulsion—Methotrexate—testicular cancer	0.000133	0.000667	CcSEcCtD
Norfloxacin—Vomiting—Etoposide—testicular cancer	0.000133	0.000667	CcSEcCtD
Norfloxacin—Erythema—Doxorubicin—testicular cancer	0.000133	0.000667	CcSEcCtD
Norfloxacin—Agitation—Epirubicin—testicular cancer	0.000132	0.000662	CcSEcCtD
Norfloxacin—Rash—Etoposide—testicular cancer	0.000132	0.000662	CcSEcCtD
Norfloxacin—Dermatitis—Etoposide—testicular cancer	0.000132	0.000661	CcSEcCtD
Norfloxacin—Headache—Etoposide—testicular cancer	0.000131	0.000657	CcSEcCtD
Norfloxacin—Flatulence—Doxorubicin—testicular cancer	0.000131	0.000657	CcSEcCtD
Norfloxacin—Myalgia—Methotrexate—testicular cancer	0.000131	0.000656	CcSEcCtD
Norfloxacin—Arthralgia—Methotrexate—testicular cancer	0.000131	0.000656	CcSEcCtD
Norfloxacin—Chest pain—Methotrexate—testicular cancer	0.000131	0.000656	CcSEcCtD
Norfloxacin—Tension—Doxorubicin—testicular cancer	0.00013	0.000654	CcSEcCtD
Norfloxacin—Dysgeusia—Doxorubicin—testicular cancer	0.00013	0.000653	CcSEcCtD
Norfloxacin—Nervousness—Doxorubicin—testicular cancer	0.000129	0.000648	CcSEcCtD
Norfloxacin—Vertigo—Epirubicin—testicular cancer	0.000129	0.000647	CcSEcCtD
Norfloxacin—Leukopenia—Epirubicin—testicular cancer	0.000129	0.000645	CcSEcCtD
Norfloxacin—Back pain—Doxorubicin—testicular cancer	0.000129	0.000645	CcSEcCtD
Norfloxacin—Muscle spasms—Doxorubicin—testicular cancer	0.000128	0.000641	CcSEcCtD
Norfloxacin—Palpitations—Epirubicin—testicular cancer	0.000127	0.000637	CcSEcCtD
Norfloxacin—Confusional state—Methotrexate—testicular cancer	0.000126	0.000634	CcSEcCtD
Norfloxacin—Anaphylactic shock—Methotrexate—testicular cancer	0.000125	0.000628	CcSEcCtD
Norfloxacin—Vision blurred—Doxorubicin—testicular cancer	0.000125	0.000628	CcSEcCtD
Norfloxacin—Convulsion—Epirubicin—testicular cancer	0.000124	0.000624	CcSEcCtD
Norfloxacin—Nausea—Etoposide—testicular cancer	0.000124	0.000623	CcSEcCtD
Norfloxacin—Thrombocytopenia—Methotrexate—testicular cancer	0.000123	0.000615	CcSEcCtD
Norfloxacin—Myalgia—Epirubicin—testicular cancer	0.000122	0.000614	CcSEcCtD
Norfloxacin—Chest pain—Epirubicin—testicular cancer	0.000122	0.000614	CcSEcCtD
Norfloxacin—Arthralgia—Epirubicin—testicular cancer	0.000122	0.000614	CcSEcCtD
Norfloxacin—Agitation—Doxorubicin—testicular cancer	0.000122	0.000613	CcSEcCtD
Norfloxacin—Anxiety—Epirubicin—testicular cancer	0.000122	0.000611	CcSEcCtD
Norfloxacin—Hyperhidrosis—Methotrexate—testicular cancer	0.000121	0.000608	CcSEcCtD
Norfloxacin—Dry mouth—Epirubicin—testicular cancer	0.00012	0.0006	CcSEcCtD
Norfloxacin—Vertigo—Doxorubicin—testicular cancer	0.000119	0.000599	CcSEcCtD
Norfloxacin—Anorexia—Methotrexate—testicular cancer	0.000119	0.000599	CcSEcCtD
Norfloxacin—Leukopenia—Doxorubicin—testicular cancer	0.000119	0.000597	CcSEcCtD
Norfloxacin—Confusional state—Epirubicin—testicular cancer	0.000118	0.000593	CcSEcCtD
Norfloxacin—Palpitations—Doxorubicin—testicular cancer	0.000117	0.000589	CcSEcCtD
Norfloxacin—Anaphylactic shock—Epirubicin—testicular cancer	0.000117	0.000588	CcSEcCtD
Norfloxacin—Oedema—Epirubicin—testicular cancer	0.000117	0.000588	CcSEcCtD
Norfloxacin—Convulsion—Doxorubicin—testicular cancer	0.000115	0.000578	CcSEcCtD
Norfloxacin—Thrombocytopenia—Epirubicin—testicular cancer	0.000115	0.000576	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000114	0.000573	CcSEcCtD
Norfloxacin—Hyperhidrosis—Epirubicin—testicular cancer	0.000113	0.000569	CcSEcCtD
Norfloxacin—Insomnia—Methotrexate—testicular cancer	0.000113	0.000568	CcSEcCtD
Norfloxacin—Myalgia—Doxorubicin—testicular cancer	0.000113	0.000568	CcSEcCtD
Norfloxacin—Arthralgia—Doxorubicin—testicular cancer	0.000113	0.000568	CcSEcCtD
Norfloxacin—Chest pain—Doxorubicin—testicular cancer	0.000113	0.000568	CcSEcCtD
Norfloxacin—Anxiety—Doxorubicin—testicular cancer	0.000113	0.000566	CcSEcCtD
Norfloxacin—Paraesthesia—Methotrexate—testicular cancer	0.000112	0.000564	CcSEcCtD
Norfloxacin—Anorexia—Epirubicin—testicular cancer	0.000112	0.000561	CcSEcCtD
Norfloxacin—Dyspnoea—Methotrexate—testicular cancer	0.000112	0.00056	CcSEcCtD
Norfloxacin—Somnolence—Methotrexate—testicular cancer	0.000111	0.000559	CcSEcCtD
Norfloxacin—Dry mouth—Doxorubicin—testicular cancer	0.000111	0.000555	CcSEcCtD
Norfloxacin—Dyspepsia—Methotrexate—testicular cancer	0.00011	0.000553	CcSEcCtD
Norfloxacin—Confusional state—Doxorubicin—testicular cancer	0.000109	0.000549	CcSEcCtD
Norfloxacin—Decreased appetite—Methotrexate—testicular cancer	0.000109	0.000546	CcSEcCtD
Norfloxacin—Oedema—Doxorubicin—testicular cancer	0.000108	0.000544	CcSEcCtD
Norfloxacin—Anaphylactic shock—Doxorubicin—testicular cancer	0.000108	0.000544	CcSEcCtD
Norfloxacin—Fatigue—Methotrexate—testicular cancer	0.000108	0.000542	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000107	0.000536	CcSEcCtD
Norfloxacin—Thrombocytopenia—Doxorubicin—testicular cancer	0.000106	0.000533	CcSEcCtD
Norfloxacin—Insomnia—Epirubicin—testicular cancer	0.000106	0.000532	CcSEcCtD
Norfloxacin—Paraesthesia—Epirubicin—testicular cancer	0.000105	0.000528	CcSEcCtD
Norfloxacin—Hyperhidrosis—Doxorubicin—testicular cancer	0.000105	0.000526	CcSEcCtD
Norfloxacin—Dyspnoea—Epirubicin—testicular cancer	0.000105	0.000524	CcSEcCtD
Norfloxacin—Somnolence—Epirubicin—testicular cancer	0.000104	0.000523	CcSEcCtD
Norfloxacin—Anorexia—Doxorubicin—testicular cancer	0.000103	0.000519	CcSEcCtD
Norfloxacin—Feeling abnormal—Methotrexate—testicular cancer	0.000103	0.000518	CcSEcCtD
Norfloxacin—Dyspepsia—Epirubicin—testicular cancer	0.000103	0.000518	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Methotrexate—testicular cancer	0.000102	0.000514	CcSEcCtD
Norfloxacin—Decreased appetite—Epirubicin—testicular cancer	0.000102	0.000511	CcSEcCtD
Norfloxacin—Fatigue—Epirubicin—testicular cancer	0.000101	0.000507	CcSEcCtD
Norfloxacin—Constipation—Epirubicin—testicular cancer	0.0001	0.000503	CcSEcCtD
Norfloxacin—Urticaria—Methotrexate—testicular cancer	9.95e-05	0.000499	CcSEcCtD
Norfloxacin—Abdominal pain—Methotrexate—testicular cancer	9.9e-05	0.000497	CcSEcCtD
Norfloxacin—Body temperature increased—Methotrexate—testicular cancer	9.9e-05	0.000497	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Doxorubicin—testicular cancer	9.88e-05	0.000496	CcSEcCtD
Norfloxacin—Insomnia—Doxorubicin—testicular cancer	9.81e-05	0.000492	CcSEcCtD
Norfloxacin—Paraesthesia—Doxorubicin—testicular cancer	9.74e-05	0.000489	CcSEcCtD
Norfloxacin—Dyspnoea—Doxorubicin—testicular cancer	9.67e-05	0.000485	CcSEcCtD
Norfloxacin—Feeling abnormal—Epirubicin—testicular cancer	9.66e-05	0.000485	CcSEcCtD
Norfloxacin—Somnolence—Doxorubicin—testicular cancer	9.64e-05	0.000484	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Epirubicin—testicular cancer	9.59e-05	0.000481	CcSEcCtD
Norfloxacin—Dyspepsia—Doxorubicin—testicular cancer	9.55e-05	0.000479	CcSEcCtD
Norfloxacin—Decreased appetite—Doxorubicin—testicular cancer	9.43e-05	0.000473	CcSEcCtD
Norfloxacin—Fatigue—Doxorubicin—testicular cancer	9.35e-05	0.000469	CcSEcCtD
Norfloxacin—Urticaria—Epirubicin—testicular cancer	9.31e-05	0.000467	CcSEcCtD
Norfloxacin—Constipation—Doxorubicin—testicular cancer	9.28e-05	0.000465	CcSEcCtD
Norfloxacin—Abdominal pain—Epirubicin—testicular cancer	9.27e-05	0.000465	CcSEcCtD
Norfloxacin—Body temperature increased—Epirubicin—testicular cancer	9.27e-05	0.000465	CcSEcCtD
Norfloxacin—Hypersensitivity—Methotrexate—testicular cancer	9.23e-05	0.000463	CcSEcCtD
Norfloxacin—Asthenia—Methotrexate—testicular cancer	8.99e-05	0.000451	CcSEcCtD
Norfloxacin—Feeling abnormal—Doxorubicin—testicular cancer	8.94e-05	0.000448	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Doxorubicin—testicular cancer	8.87e-05	0.000445	CcSEcCtD
Norfloxacin—Pruritus—Methotrexate—testicular cancer	8.86e-05	0.000445	CcSEcCtD
Norfloxacin—Hypersensitivity—Epirubicin—testicular cancer	8.64e-05	0.000433	CcSEcCtD
Norfloxacin—Urticaria—Doxorubicin—testicular cancer	8.62e-05	0.000432	CcSEcCtD
Norfloxacin—Abdominal pain—Doxorubicin—testicular cancer	8.57e-05	0.00043	CcSEcCtD
Norfloxacin—Body temperature increased—Doxorubicin—testicular cancer	8.57e-05	0.00043	CcSEcCtD
Norfloxacin—Diarrhoea—Methotrexate—testicular cancer	8.57e-05	0.00043	CcSEcCtD
Norfloxacin—Asthenia—Epirubicin—testicular cancer	8.41e-05	0.000422	CcSEcCtD
Norfloxacin—Pruritus—Epirubicin—testicular cancer	8.29e-05	0.000416	CcSEcCtD
Norfloxacin—Dizziness—Methotrexate—testicular cancer	8.28e-05	0.000416	CcSEcCtD
Norfloxacin—Diarrhoea—Epirubicin—testicular cancer	8.02e-05	0.000402	CcSEcCtD
Norfloxacin—Hypersensitivity—Doxorubicin—testicular cancer	7.99e-05	0.000401	CcSEcCtD
Norfloxacin—Vomiting—Methotrexate—testicular cancer	7.96e-05	0.0004	CcSEcCtD
Norfloxacin—Rash—Methotrexate—testicular cancer	7.9e-05	0.000396	CcSEcCtD
Norfloxacin—Dermatitis—Methotrexate—testicular cancer	7.89e-05	0.000396	CcSEcCtD
Norfloxacin—Headache—Methotrexate—testicular cancer	7.85e-05	0.000394	CcSEcCtD
Norfloxacin—Asthenia—Doxorubicin—testicular cancer	7.78e-05	0.00039	CcSEcCtD
Norfloxacin—Dizziness—Epirubicin—testicular cancer	7.75e-05	0.000389	CcSEcCtD
Norfloxacin—Pruritus—Doxorubicin—testicular cancer	7.67e-05	0.000385	CcSEcCtD
Norfloxacin—Vomiting—Epirubicin—testicular cancer	7.45e-05	0.000374	CcSEcCtD
Norfloxacin—Nausea—Methotrexate—testicular cancer	7.44e-05	0.000373	CcSEcCtD
Norfloxacin—Diarrhoea—Doxorubicin—testicular cancer	7.42e-05	0.000372	CcSEcCtD
Norfloxacin—Rash—Epirubicin—testicular cancer	7.39e-05	0.000371	CcSEcCtD
Norfloxacin—Dermatitis—Epirubicin—testicular cancer	7.38e-05	0.000371	CcSEcCtD
Norfloxacin—Headache—Epirubicin—testicular cancer	7.34e-05	0.000368	CcSEcCtD
Norfloxacin—Dizziness—Doxorubicin—testicular cancer	7.17e-05	0.00036	CcSEcCtD
Norfloxacin—Nausea—Epirubicin—testicular cancer	6.96e-05	0.000349	CcSEcCtD
Norfloxacin—Vomiting—Doxorubicin—testicular cancer	6.9e-05	0.000346	CcSEcCtD
Norfloxacin—Rash—Doxorubicin—testicular cancer	6.84e-05	0.000343	CcSEcCtD
Norfloxacin—Dermatitis—Doxorubicin—testicular cancer	6.83e-05	0.000343	CcSEcCtD
Norfloxacin—Headache—Doxorubicin—testicular cancer	6.79e-05	0.000341	CcSEcCtD
Norfloxacin—Nausea—Doxorubicin—testicular cancer	6.44e-05	0.000323	CcSEcCtD
